CAR T cell therapy for multiple myeloma: where are we now and where are we headed?

Overview of attention for article published in Leukemia & Lymphoma, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 4,806)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs: 1 blog

twitter: 36 X users

Readers on

mendeley: 113 Mendeley

So far, Altmetric has seen 43 X posts from 36 X users, with an upper bound of 108,854 followers.

CAR-T療法と骨髄腫 CAR T cell therapy for multiple myeloma: where are we now and where are we headed?: Leukemia & Lymphoma: Vol 59, No 9 https://t.co/jeytggeUam

RT @DrOlaLandgren: CAR T cell therapy for multiple myeloma: where are we now and where are we headed? Rapidly changing treatment field of m…

CAR T cell therapy – What's new? What you'll want to know.

RT @DrOlaLandgren: CAR T cell therapy for multiple myeloma: where are we now and where are we headed? Rapidly changing treatment field of m…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 39 additional X posts.